Corcept Therapeutics (CORT) PT Raised to $78 at Canaccord Genuity
Tweet Send to a Friend
(Updated - July 31, 2024 6:27 AM EDT)
Canaccord Genuity analyst Edward Nash raised the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord Genuity analyst Edward Nash raised the price target on Corcept ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
